⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for cd20 ,follicular lymphoma,marginal zone lymphoma,mil62

Every month we try and update this database with for cd20 ,follicular lymphoma,marginal zone lymphoma,mil62 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)NCT04110301
Follicular Lymp...
Recombinant Hum...
Lenalidomide
18 Years - Beijing Mabworks Biotech Co., Ltd.
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)NCT04110301
Follicular Lymp...
Recombinant Hum...
Lenalidomide
18 Years - Beijing Mabworks Biotech Co., Ltd.
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)NCT04110301
Follicular Lymp...
Recombinant Hum...
Lenalidomide
18 Years - Beijing Mabworks Biotech Co., Ltd.
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)NCT04110301
Follicular Lymp...
Recombinant Hum...
Lenalidomide
18 Years - Beijing Mabworks Biotech Co., Ltd.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: